Literature DB >> 4583162

Five day primaquine therapy--an evaluation of radical curative activity against vivax malaria infection.

P G Contacos, G R Coatney, W E Collins, P E Briesch, M H Jeter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4583162     DOI： 10.4269/ajtmh.1973.22.693

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  2 in total

1.  Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.

Authors:  Cindy S Chu; Aung Pyae Phyo; Claudia Turner; Htun Htun Win; Naw Pet Poe; Widi Yotyingaphiram; Suradet Thinraow; Pornpimon Wilairisak; Rattanaporn Raksapraidee; Verena I Carrara; Moo Kho Paw; Jacher Wiladphaingern; Stéphane Proux; Germana Bancone; Kanlaya Sriprawat; Sue J Lee; Atthanee Jeeyapant; James Watson; Joel Tarning; Mallika Imwong; François Nosten; Nicholas J White
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

2.  Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.

Authors:  Michael T White; George Shirreff; Stephan Karl; Azra C Ghani; Ivo Mueller
Journal:  Proc Biol Sci       Date:  2016-03-30       Impact factor: 5.349
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.